What is CEEP regimen used for?

CEEP regimen is indicated for Acute lymphoblastic leukemia.

Who makes CEEP regimen?

CEEP regimen is developed by French Innovative Leukemia Organisation.

What are the side effects of CEEP regimen?

Common side effects include Nausea, Vomiting, Fatigue, Hair loss, Infection.

Last reviewed 2026-04-23 · How we verify

CEEP regimen

French Innovative Leukemia Organisation · Phase 2 active Small molecule

CEEP regimen is a combination of chemotherapy drugs used to treat acute lymphoblastic leukemia.

CEEP regimen is a combination of chemotherapy drugs used to treat acute lymphoblastic leukemia. Used for Acute lymphoblastic leukemia.

At a glance

Generic name	CEEP regimen
Sponsor	French Innovative Leukemia Organisation
Drug class	chemotherapy regimen
Modality	Small molecule
Therapeutic area	Oncology
Phase	Phase 2

Mechanism of action

The CEEP regimen is a combination of cyclophosphamide, etoposide, epirubicin, and prednisone. It works by targeting rapidly dividing cancer cells and inhibiting their growth and proliferation.

Approved indications

Acute lymphoblastic leukemia

Common side effects

Nausea
Vomiting
Fatigue
Hair loss
Infection

Key clinical trials

Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CEEP regimen CI brief — competitive landscape report
CEEP regimen updates RSS · CI watch RSS
French Innovative Leukemia Organisation portfolio CI